Chiara Carcieri

A UHPLC–MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma

Alessandra Ariaudo, F. Favata, Amedeo De Nicolò et al. · Journal of Pharmaceutical and Biomedical Analysis · 2016 · 125 citations · Full text

Medicine, Antiviral Drug Development, Antiviral Therapy +8

Cannabinoids concentration variability in cannabis olive oil galenic preparations

Chiara Carcieri, Cristina Tomasello, Marco Simiele et al. · Journal of Pharmacy and Pharmacology · 2017 · 63 citations · Full text

Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children

Sarah Allegra, Giovanna Fatiguso, Silvia De Francia et al. · British Journal of Clinical Pharmacology · 2017 · 56 citations · Full text

Pharmacotherapy, Voriconazole Concentration, Drug Resistance +16

UPLC–MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma

Marco Simiele, Alessandra Ariaudo, Amedeo De Nicolò et al. · Journal of Pharmaceutical and Biomedical Analysis · 2017 · 51 citations

Medicine, Uplc–ms/ms Method, Antiviral Drug Development +10

Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms

Antonio D’Avolio, Chiara Carcieri, Jessica Cusato et al. · Journal of Antimicrobial Chemotherapy · 2014 · 41 citations · Full text